■ Essilor International announced it has agreed to acquire the 51% stake in Transitions Optical owned by PPG. With the agreement, valued at $1.73 billion (according to Bloomberg.com), Essilor will own 100% of the capital of Transitions.

■ TearLab Corporation announced the pricing of an underwritten public offering of 2.6 million shares of its common stock at a price to the public of $13.50 per share.

■ Bausch + Lomb announced it acquired, from Montreal’s Mimetogen Pharmaceuticals, an option to license an investigational compound for the treatment of dry eye syndrome currently in Phase 2 development.

■ CooperVision appointed Juan Carlos Aragon, O.D., to senior vice president, Global Professional & Clinical Affairs. Also, Andrew Sedgwick has been appointed to executive vice president of Commercial Strategy and Business Development.

■ Prevent Blindness America (PBA) has declared August Children’s Eye Health and Safety Month. The organization offers educators the Star Pupils Health and Safety Curriculum. For parents, PBA offers free information on its website, www.preventblindness.org.

■ Vision Source announced the addition of Neil Godbey to the organization’s board of directors. Mr. Godbey is the president and CEO of The Godbey Group and chairman and CEO of Advanced Plan for Health.

■ SynergEyes has promoted James Kirchner, O.D., to president. Dr. Kirchner previously served as senior vice president of clinical and professional affairs.